Literature DB >> 7002161

Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).

M J Tisdale, A D Habberfield.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7002161     DOI： 10.1016/0006-2952(80)90021-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  3 in total

1.  CB 1954 revisited. II. Toxicity and antitumour activity.

Authors:  P Workman; J E Morgan; K Talbot; K A Wright; J Donaldson; P R Twentyman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  CB 1954 revisited. I. Disposition kinetics and metabolism.

Authors:  P Workman; R A White; K Talbot
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 3.  The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).

Authors:  R J Knox; F Friedlos; M P Boland
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.